Navigation Links
Eniva USA Efacor(R) Fish Oil (Non-Fishy Lemon Taste) Receives ConsumerLab.com Seal of Approval
Date:8/4/2008

MINNEAPOLIS, Aug. 4 /PRNewswire/ -- Another Eniva nutraceutical moves to the forefront of those supplements known for their excellent quality and valid claims. Eniva's Efacor has recently received industry recognition for ensuring product quality standards from ConsumerLab.com. ConsumerLab.com (CL) has long been recognized as the "gold-testing standard" for safety and quality among nutritional products. CL's stringent testing of the Eniva Efacor product has resulted in CL's issuance of its "Approved Quality" seal, or stamp of quality approval, for the Omega-3 dietary supplement.

As an independent certification company, ConsumerLab.com -- usually known by their "CL" initials -- provides testing for a large number of dietary and healthcare manufacturers. Products are tested for specific ingredient claims and held to additional quality standards. In a competitive consumer environment, the CL approval seal is an added mark of assurance for individuals consuming a dietary or health product.

The CL "Approved Quality" seal will be appearing on all Efacor bottles. Responding to the approval, Eniva Chief Medical Officer, Dr. Benjamin Baechler said, "With so much emphasis on heart health today, consumers are looking for Omega-3 products. With Efacor, the consumer is not only getting the supplement they need, they are getting a product that is produced with the values of exceptional quality, safety and effectiveness. Plus, its high dose EPA and DHA are also excellent for the eyes, joints and brain." Added Eniva CEO Andrew Baechler, "We have always believed our Efacor product was outstanding in terms of innovation and impact ... now we can even more confidently share that reassuring news with others who are seeking a healthy way to get their daily needs met for omega-3s."

Research has shown that a diet rich in omega-3s, particularly EPA and DHA, can help support normal and healthy blood pressure, cardiac health, normal brain development and function, eye health, reduced inflammation in the body, joint health, and positive mood.

In the multi-billion dollar health products industry, ConsumerLab.com stands out as a leader in the analysis of health and nutrition products, independently testing and certifying a multitude of health and nutrition products. CL's testing encourages manufactures to pay closer attention to the quality standards of the products manufactured by applying a higher standard than required by law. Supplements certified indicate that the manufacturer has responsibly followed the correct steps in labeling its products for the general public. Consumers of Eniva products can look for more CL "Approved Quality" seals on additional Eniva products in the future.

As the regulation of dietary supplements continues to become more rigorous, and the consumer demand for supplementation expands, the testing results for such products will be indispensable. Through the assistance of CL, users of Efacor can be assured the product incorporates the highest standards of quality and safety.

Eniva, located in Minneapolis, MN, designs, manufactures and distributes concentrated liquid nutritional supplements and other body support products. Founded in 1998, Eniva has earned the distinction of being a pioneer of advanced liquid nutraceutical products and innovative nutrient delivery systems. For more information, visit http://www.eniva.com.

Research study references on file, Eniva USA, 2008.


'/>"/>
SOURCE Eniva
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Photos: MIKE AND IKE(R) Lemonade Blends(TM) and Alexs Lemonade Stand Foundation Join facebook(R)
2. Thirsty for a Cause? Try Some Virtual Lemonade!
3. MIKE AND IKE(R) Lemonade Blends(TM) Presents $100,000 to Alexs Lemonade Stand Foundation
4. Sour comes after a lemon has gone
5. Kids Squeeze Aid Out of Lemons as Take a Stand(R) Program Launches Nationwide
6. True Orange Joins the True Lemon & True Lime Family
7. Novant Health(R) Selects Cardiocom(R) to Provide Telemonitoring for Presbyterian Hospital Heart Failure Program
8. University of South Florida receives new multimillion award to assess juvenile diabetes treatments
9. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
10. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
11. Go Healthy Receives Letter of Recognition From the Texas Chiropractic Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... St. Catherine’s Village announced ... Siena Center is a skilled nursing facility on the grounds of the St. Catherine’s ... It recently was voted the best nursing home in Mississippi for the second year ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... at Reproductive Medicine Associates of Connecticut (RMACT) have earned “Top Doctor” awards. ... and Dr. Shaun Williams have each been chosen by their peers for the ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) is proud and excited ... compassionate dermatologist. Dr. Kim brings an extensive background in cutting-edge dermatology care and ... pleasure to welcome back Dr. Kim to the CDG team” said President and Managing ...
(Date:1/19/2017)... ... January 19, 2017 , ... "ProParagraph Basics ... simplify the editing process for all media productions," said Christina Austin - CEO ... 30 simplistically styled self-animating paragraphs designed for multi-lined text purposes. Choose from ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... of the American Osteopathic College of Proctology) announced today the opening of ... Southern California ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... India , January 18, 2017 ... Imaging Technologies Market by Type: Global Opportunity Analysis and Industry ... size was valued at $2,544 million in 2015 and is ... CAGR of 8.4% from 2016 to 2022. North ... accounted for over three-fourths market share in 2015. Ionizing breast ...
(Date:1/18/2017)... N.J. , Jan. 18, 2017   Regenicin, ... a biotechnology company specializing in the development and commercialization ... damaged tissues and organs, recently reported the Company,s operating ... for 2017. As the Company described in ... been a year of substantial accomplishments. The Company,s contract ...
(Date:1/18/2017)... , Suiza, 18 de enero de 2017 /PRNewswire/ ... líderes lanzaron Access Accelerated, una iniciativa global para avanzar ... (NCD) y atención en países de renta baja y ... han alcanzado un punto de crisis, particularmente en países ... el 80 por ciento de las muertes relacionadas con ...
Breaking Medicine Technology: